Influenza overview: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(14 intermediate revisions by 4 users not shown)
Line 1: Line 1:
<div style="-webkit-user-select: none;">
{|class="infobox" style="position: fixed; top: 65%; right: 10px; margin: 0 0 0 0; border: 0; float: right;
|-
| {{#ev:youtube|https://https://www.youtube.com/watch?v=T_me5EF0ne4&t=5s |350}}
|-
|}
__NOTOC__
__NOTOC__
{{Influenza}}
{{Influenza}}
'''For more information about non-human (variant) influenza viruses that may be transmitted to humans, see [[Zoonotic influenza]]'''
{{CMG}}; {{AE}} {{AL}}
{{CMG}}; {{AE}} {{AL}}


== Overview==
== Overview==
Influenza, commonly known as flu, is an [[infectious disease]] of birds and [[mammal]]s caused by  [[RNA virus]]es of the biological family [[Orthomyxoviridae]] (the influenza viruses). In humans, common symptoms of influenza infection are [[fever]], [[pharyngitis|sore throat]], [[myalgia|muscle pains]], severe [[headache]], [[cough]]ing, [[fatigue (medical)|weakness]] and [[malaise|general discomfort]].<ref name=Merck>{{cite web |author= Merck Manual Home Edition |title=Influenza: Viral Infections |url= http://www.merck.com/mmhe/sec17/ch198/ch198c.html?}}</ref> In more serious cases, influenza [[sequela|causes]] [[pneumonia]], which can be fatal, particularly in young children and the elderly. Sometimes confused with the [[common cold]], influenza is a much more severe disease and is caused by a different type of virus.<ref name=Eccles>{{cite journal | last = Eccles | first = R | title = Understanding the symptoms of the common cold and influenza | journal = Lancet Infect Dis | volume = 5 | issue = 11 | pages = 718–25 | year = 2005 | id = PMID 16253889}}</ref> Although [[nausea]] and [[vomiting]] can be produced, especially in children,<ref name=Merck/> these symptoms are more characteristic of the unrelated [[gastroenteritis]], which is sometimes called "stomach flu" or "24-hour flu."<ref> [http://coldflu.about.com/od/flumisconceptions/f/stomachflu.htm Seasonal Flu vs. Stomach Flu] by Kristina Duda, R.N.; accessed March 12, 2007 (Website: "About, Inc., A part of The New York Times Company")</ref>
Influenza, commonly known as flu, is an [[infectious disease]] of birds and [[mammal]]s caused by  [[RNA virus]]es of the biological family [[Orthomyxoviridae]] (the influenza viruses). In humans, common symptoms of influenza infection are [[fever]], [[pharyngitis|sore throat]], [[myalgia|muscle pains]], severe [[headache]], [[cough]]ing, [[fatigue (medical)|weakness]] and [[malaise|general discomfort]].<ref name=Merck>{{cite web |author= Merck Manual Home Edition |title=Influenza: Viral Infections |url= http://www.merck.com/mmhe/sec17/ch198/ch198c.html?}}</ref> In more serious cases, influenza [[sequela|causes]] [[pneumonia]], which can be fatal, particularly in young children and the elderly. Sometimes confused with the [[common cold]], influenza is a much more severe disease and is caused by a different type of virus.<ref name=Eccles>{{cite journal | last = Eccles | first = R | title = Understanding the symptoms of the common cold and influenza | journal = Lancet Infect Dis | volume = 5 | issue = 11 | pages = 718–25 | year = 2005 | id = PMID 16253889}}</ref> Although [[nausea]] and [[vomiting]] can be produced, especially in children,<ref name=Merck/> these symptoms are more characteristic of the unrelated [[gastroenteritis]].<ref> [http://coldflu.about.com/od/flumisconceptions/f/stomachflu.htm Seasonal Flu vs. Stomach Flu] by Kristina Duda, R.N.; accessed March 12, 2007 (Website: "About, Inc., A part of The New York Times Company")</ref>


== Historical Perspective ==
== Historical Perspective ==
Influenza-like symptoms have been reported for many thousandth of years, but the first pandemic outbreak was in Asia, Europe and Africa in 1580.  Since then, several outbreaks have been reported, including the Spanish flu pandemic in 1918, the Asian flu pandemic in 1957, and the Hong Kong flu pandemic in 1968.  The first vaccine against influenza was developed in 1940s to prevent the US military to develop the disease in World War II.


== Classification ==
== Classification ==
Line 15: Line 24:


== Causes ==
== Causes ==
Influenza infection is caused by the influenza virus that belong to the family [[Orthomyxoviridae]].  Three types of influenza virus  have been reported to cause clinical illness in humans: types A, B, and C.  Influenza virus can be found in humans, as well as in poultry, pigs, and bats.


== Differentiating Influenza from other Diseases ==
== Differentiating Influenza from other Diseases ==
Line 26: Line 36:


== Natural History, Complications and Prognosis ==
== Natural History, Complications and Prognosis ==
Influenza is a viral respiratory infection spread from person to person chiefly through droplet transmission. The incubation period period if 1-4 days. The uncomplicated influenza can present with constitutional symptoms and can resolve in 3-7 days while others can develop into [[pneumonia]] , [[ear infection]], [[encephalitis]] and [[sepsis]].
Influenza is a viral [[respiratory infection]] spread from person to person chiefly through droplet transmission. The incubation period period is 1 to 4 days. The uncomplicated influenza can present with constitutional symptoms and can resolve in 3-7 days; while others can develop into [[pneumonia]], [[ear infection]], [[encephalitis]] and [[sepsis]].


== Diagnosis ==
== Diagnosis ==
Line 48: Line 58:


=== Medical Therapy ===
=== Medical Therapy ===
Antiviral drugs can diminish symptoms and shorten the time of the disease by 1 or 2 days.  They also can prevent serious flu complications, such as [[pneumonia]].  For people with a high risk medical condition, treatment with an [[antiviral drug]] can mean the difference between having milder illness instead of very serious illness that could result in a hospital stay.  The two main antivirals used in the treatment and prevention of influenza are [[oseltamivir]] and [[zanamivir]].  Symptomatic therapy is also important to overcome the symptoms of influenza, this include [[analgesics]], [[antihistamines]], [[decongestants]] and [[cough suppressant]]s.


=== Primary Prevention ===
=== Primary Prevention ===
[[Vaccination]] and [[chemoprophylaxis]] are the two most important methods for preventing influenza among patients.  Routine annual [[influenza vaccination]] is recommended for all persons aged ≥6 months who do not have contraindications.  Annual influenza [[vaccination]] is the best way to prevent influenza because [[vaccination]] can be given well before influenza virus exposures occur, and can provide safe and effective immunity throughout the influenza season.  [[Chemoprophylaxis]] is not recommended in all patients and should only be administered for certain populations who are at risk of complications.


=== Cost-Effectiveness of Therapy ===
=== Cost-Effectiveness of Therapy ===
Influenza produces [[variable cost|direct cost]]s due to lost [[productivity]] and associated medical treatment, as well as [[indirect costs]] of preventative measures. In the United States, influenza is responsible for a total cost of over $10 billion per year, while it has been estimated that a future pandemic could cause hundreds of billions of dollars in direct and indirect costs. However, the economic impact of past pandemics have not been intensively studied, and some authors have suggested that the [[Spanish flu|Spanish influenza]] actually had a positive long-term effect on per-capita income growth, despite a large reduction in the working population and severe short-term depressive effects.<ref>Brainerd, E. and M. Siegler (2003), “The Economic Effects of the 1918 Influenza Epidemic”, ''CEPR Discussion Paper'', no. 3791.</ref> Other studies have attempted to predict the costs of a pandemic as serious as the 1918 Spanish flu on the U.S. economy, where 30% of all workers became ill, and 2.5% were killed. A 30% sickness rate and a three-week length of illness would decrease [[gross domestic product]] by 5%. Additional costs would come from medical treatment of 18 million to 45 million people, and total economic costs would be approximately $700 billion.<ref>{{cite journal | author = Poland G | title = Vaccines against avian influenza—a race against time. | url=http://content.nejm.org/cgi/content/full/354/13/1411 | journal = N Engl J Med | volume = 354 | issue = 13 | pages = 1411–3 | year = 2006 | id = PMID 16571885}}</ref>


=== Future or Investigational Therapies ===
=== Future or Investigational Therapies ===
 
Other antiviral drugs are being developed to treat influenza infection, such as [[peramivir]].  [[Vaccines]] are manufactured every year according to the subtype of influenza virus that causes the outbreak in that specific year.
<!---
=== Overview ===
Influenza, commonly known as flu, is an [[infectious disease]] of birds and [[mammal]]s caused by  [[RNA virus]]es of the biological family [[Orthomyxoviridae]] (the influenza viruses). In humans, common symptoms of influenza infection are [[fever]], [[pharyngitis|sore throat]], [[myalgia|muscle pains]], severe [[headache]], [[cough]]ing, [[fatigue (medical)|weakness]] and [[malaise|general discomfort]].<ref name=Merck>{{cite web |author= Merck Manual Home Edition |title=Influenza: Viral Infections |url= http://www.merck.com/mmhe/sec17/ch198/ch198c.html?}}</ref> In more serious cases, influenza [[sequela|causes]] [[pneumonia]], which can be fatal, particularly in young children and the elderly. Sometimes confused with the [[common cold]], influenza is a much more severe disease and is caused by a different type of virus.<ref name=Eccles>{{cite journal | last = Eccles | first = R | title = Understanding the symptoms of the common cold and influenza | journal = Lancet Infect Dis | volume = 5 | issue = 11 | pages = 718–25 | year = 2005 | id = PMID 16253889}}</ref> Although [[nausea]] and [[vomiting]] can be produced, especially in children,<ref name=Merck/> these symptoms are more characteristic of the unrelated [[gastroenteritis]], which is sometimes called "stomach flu" or "24-hour flu."<ref> [http://coldflu.about.com/od/flumisconceptions/f/stomachflu.htm Seasonal Flu vs. Stomach Flu] by Kristina Duda, R.N.; accessed March 12, 2007 (Website: "About, Inc., A part of The New York Times Company")</ref>
Typically, influenza is transmitted from infected mammals through the air by coughs or sneezes, creating particulates/aerosols containing the virus, and from infected birds through their [[feces|droppings]].  Influenza can also be transmitted by [[saliva]], [[mucus|nasal secretions]], [[feces]] and [[blood]].  Infections also occur through contact with these body fluids or with contaminated surfaces.
Flu viruses can remain infectious for about one week at human body temperature, over 30 days at 0 °C (32 °F), and indefinitely at very low temperatures (such as lakes in northeast Siberia). Most influenza strains can be inactivated easily by [[disinfectant]]s and [[detergent]]s.<ref>{{cite journal | last = Suarez | first = D | coauthors = Spackman E, Senne D, Bulaga L, Welsch A, Froberg K | title = The effect of various disinfectants on detection of avian influenza virus by real time RT-PCR | journal = Avian Dis | volume = 47 | issue = 3 Suppl | pages = 1091–5 | year = 2003 | id = PMID 14575118}}</ref><ref>[http://www.cidrap.umn.edu/cidrap/content/influenza/avianflu/biofacts/avflu_human.html  Avian Influenza (Bird Flu)]: Implications for Human Disease.  Physical characteristics of influenza A viruses.  UMN CIDRAP.</ref><ref name = "NHZ2006-11-30">[http://www.nzherald.co.nz/category/story.cfm?c_id=204&objectid=10413124 Flu viruses 'can live for decades' on ice], NZ Herald, November 30, 2006.</ref>
Flu spreads around the world in seasonal [[epidemic]]s, killing millions of people in [[pandemic]] years and hundreds of thousands in non-pandemic years. Three influenza pandemics occurred in the 20th century and killed tens of millions of people, with each of these pandemics being caused by the appearance of a new [[strain (biology)|strain]] of the virus in humans. Often, these new strains result from the spread of an existing flu virus to humans from other animal [[species]].
Since it first killed humans in Asia in the 1990s, a deadly avian strain named [[H5N1]] has posed the greatest risk for a new [[influenza pandemic]]; fortunately, this virus has not [[mutation|mutated]] to a form that spreads easily between people.<ref>{{cite web | title=Avian influenza ("bird flu") fact sheet | url= http://www.who.int/mediacentre/factsheets/avian_influenza/en/ | date=February 2006 | publisher=WHO | accessdate=2006-10-20}}</ref>
 
[[Vaccination]]s against influenza are most commonly given to high-risk humans in industrialized countries<ref name=WHOvaccines>[http://www.who.int/wer/2005/wer8033.pdf WHO position paper: influenza vaccines] ''WHO weekly Epidemiological Record'' 19 August 2005, vol. 80, 33, pp. 277–288.</ref> and to farmed poultry.<ref>{{cite journal | last = Villegas | first = P | title = Viral diseases of the respiratory system | journal = Poult Sci | volume = 77 | issue = 8 | pages = 1143–5 | year = 1998 | id = PMID 9706079}}</ref> The most common human vaccine is the trivalent [[flu vaccine]] that contains purified and inactivated material from three viral strains. Typically this vaccine includes material from two [[influenzavirus A|influenza A virus]] subtypes and one [[Influenzavirus B|influenza B virus]] strain.<ref>{{cite journal | last = Horwood | first = F | coauthors = Macfarlane J | title = Pneumococcal and influenza vaccination: current situation and future prospects. | url= http://thorax.bmjjournals.com/cgi/reprint/57/suppl_2/ii24.pdf | journal = Thorax | volume = 57 Suppl 2 | issue = | pages = II24–II30 | year = | id = PMID 12364707}}</ref> A vaccine formulated for one year may be ineffective in the following year, since the influenza virus changes rapidly over time and different strains become dominant.  [[Antiviral drug]]s can be used to treat influenza, with [[neuraminidase inhibitor]]s being particularly effective.
 
=== Diagnosis ===
==== History and Symptoms ====
In humans, influenza's effects are much more severe than those of the [[common cold]], and last longer. Recovery takes about one to two weeks. Influenza, however, can be deadly, especially for the weak, old or chronically ill.
 
=== Treatment ===
==== Future or Investigational Therapies ====
 
Research on influenza includes studies on [[molecular virology]], how the virus produces disease ([[pathogenesis]]), host [[immune response]]s, [[genomics|viral genomics]], and how the virus spreads ([[epidemiology]]). These studies help in developing influenza countermeasures; for example, a better understanding of the body's immune response helps [[vaccine]] development, and a detailed picture of how influenza invades cells aids the development of antiviral drugs. One important basic research program is the [[Influenza Genome Sequencing Project]], which is creating a library of influenza sequences; this library should help clarify which factors make one strain more lethal than another, which genes most affect [[immunogenicity]], and how the virus [[evolution|evolves]] over time.<ref> [http://msc.tigr.org/infl_a_virus/index.shtml Influenza A Virus Genome Project] at The Institute of Genomic Research. Accessed 19 Oct 06</ref>
 
Research into new vaccines is particularly important: as current vaccines are slow and expensive to produce and must be reformulated every year. The sequencing of the influenza genome and [[recombinant DNA]] technology may accelerate the generation of new vaccine strains by allowing scientists to substitute new antigens into a previously-developed vaccine strain.<ref>{{cite journal | author = Subbarao K, Katz J | title = Influenza vaccines generated by reverse genetics. | journal = Curr Top Microbiol Immunol | volume = 283 | issue = | pages = 313-42 | year = | id = PMID 15298174}}</ref> New technologies are also being developed to grow virus in [[cell culture]]; which promises higher yields, less cost, better quality and surge capacity.<ref>{{cite journal | author = Bardiya N, Bae J | title = Influenza vaccines: recent advances in production technologies. | url=http://www.springerlink.com/content/jdt26gc39v4bwk9q/ | journal = Appl Microbiol Biotechnol | volume = 67 | issue = 3 | pages = 299–305 | year = 2005 | id = PMID 15660212}}</ref> The U.S. government has purchased from [[Sanofi Pasteur]] and [[Chiron Corporation]] several million doses of vaccine meant to be used in case of an [[influenza pandemic]] of [[H5N1]] avian influenza and is conducting clinical trials with these vaccines.<ref> [http://www.nytimes.com/2006/03/30/health/30vaccine.html?_r=1&oref=slogin New York Times article ""Doubt Cast on Stockpile of a Vaccine for Bird Flu""] by Denise Grady. Published: March 30, 2006. Accessed 19 Oct 06</ref> The UK government is also stockpiling millions of antiviral drugs(tamiflu, oseltamivir, zanimivir) to give to its citizens in the event of an outbreak, the UK [[Health Protection Agency]] has also gathered a limited amount of HPAI H5N1 vaccines for experimental purposes.
 
'''Influenza research''' involves investigating [[molecular virology]], [[pathogenesis]], host [[immune response]]s, [[genomics]], and [[epidemiology]] regarding [[influenza]]. The main goal of research is to develop influenza countermeasures such as [[vaccine]]s, therapies and diagnostic tools.
 
The potential [[H5N1]] pandemic has motivated a huge increase in flu research. At least 12 companies and 17 governments are developing pre-pandemic [[influenza vaccine]]s in 28 different clinical trials that, if successful, could turn a deadly pandemic infection into a nondeadly pandemic infection. A vaccine that could prevent any illness at all from the not-yet-existing pandemic influenza strain will take at least three months from the virus's emergence until full-scale vaccine production could begin; with vaccine production hoped to increase until one billion doses are produced by one year after the virus is first identified.<ref> [http://www.scidev.net/gateways/index.cfm?fuseaction=readitem&rgwid=2&item=Features&itemid=515&language=1 Science and Development Network] article ''Pandemic flu: fighting an enemy that is yet to exist'' published May 3, 2006.</ref>
 
Improved influenza countermeasures require basic research on how viruses enter cells, replicate, mutate, evolve into new strains and induce an immune response. Solutions to limitations in current vaccine methods are being researched.
 
The [[Influenza Genome Sequencing Project]] is creating a library of influenza sequences that will help us understand what makes one strain more lethal than another, what genetic determinants most affect [[immunogenicity]], and how the virus evolves over time.
 
--->


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WS}}


[[Category:Disease]]
[[Category:Disease]]
[[Category:Pulmonology]]
[[Category:Pulmonology]]
[[Category:Influenza| ]]
[[Category:Influenza| ]]
[[Category:Infectious disease]]
[[Category:Primary care]]
{{WH}}
{{WS}}

Latest revision as of 22:24, 29 July 2020

https://https://www.youtube.com/watch?v=T_me5EF0ne4&t=5s |350}}

Influenza Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Influenza from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Influenza overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Influenza overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Influenza overview

CDC on Influenza overview

Influenza overview in the news

Blogs on Influenza overview

Directions to Hospitals Treating Influenza

Risk calculators and risk factors for Influenza overview

For more information about non-human (variant) influenza viruses that may be transmitted to humans, see Zoonotic influenza

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

Influenza, commonly known as flu, is an infectious disease of birds and mammals caused by RNA viruses of the biological family Orthomyxoviridae (the influenza viruses). In humans, common symptoms of influenza infection are fever, sore throat, muscle pains, severe headache, coughing, weakness and general discomfort.[1] In more serious cases, influenza causes pneumonia, which can be fatal, particularly in young children and the elderly. Sometimes confused with the common cold, influenza is a much more severe disease and is caused by a different type of virus.[2] Although nausea and vomiting can be produced, especially in children,[1] these symptoms are more characteristic of the unrelated gastroenteritis.[3]

Historical Perspective

Influenza-like symptoms have been reported for many thousandth of years, but the first pandemic outbreak was in Asia, Europe and Africa in 1580. Since then, several outbreaks have been reported, including the Spanish flu pandemic in 1918, the Asian flu pandemic in 1957, and the Hong Kong flu pandemic in 1968. The first vaccine against influenza was developed in 1940s to prevent the US military to develop the disease in World War II.

Classification

Influenza virus can be classified into 3 main types: A, B and C. Based on the surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA), influenza type A is subclassified into several subtypes and can infect many species, including humans. Type B can only infect humans and type C is not that common and causes mild illness.

Pathophysiology

Influenza virus is under constant evolutionary change. These genetic changes may be small and continuous or large and abrupt. Small genetic changes happen continuously in Type A and Type B influenza as the virus makes copies of itself. This process is called antigenic drift. Drifting happens frequently enough to make new strains of virus unrecognizable to the human immune system. Type A influenza also undergoes infrequent and sudden changes known as antigenic shift. Antigenic shift occurs when two different flu strains infect the same cell and combine portions of their genetic material. The novel assortment of HA and/or NA proteins in a shifted virus may create a new influenza A subtype. Influenza viruses spread mainly through tiny droplets expelled when people with the disease cough, sneeze, or talk. These droplets can land in the mouths or noses of people who are nearby or be inhaled into the lungs.

Causes

Influenza infection is caused by the influenza virus that belong to the family Orthomyxoviridae. Three types of influenza virus have been reported to cause clinical illness in humans: types A, B, and C. Influenza virus can be found in humans, as well as in poultry, pigs, and bats.

Differentiating Influenza from other Diseases

Influenza should be differentiated from other conditions that cause fever, cough, myalgias, headache and fatigue, such as RSV infection, dengue fever, parainfluenza virus infection, ebola infection adenovirus infection, rhinovirus infection, and legionella infection.

Epidemiology and Demographics

The CDC estimates that 5 to 20 percent of Americans are affected by the flu during each flu season, which typically lasts from October to March. Children are 2 to 3 times more likely than adults to get sick with the flu, and children frequently spread the virus to others. For elderly people, newborn babies, pregnant women, and people with certain chronic illnesses, the flu and its complications can be life-threatening. Although most people recover from the illness, between 3,000 and 49,000 US citizens die from the flu and its complications every year.[4]

Risk Factors

Risk factors for influenza are for those patients that are exposed to the disease, such as healthcare workers, residents of nursing homes or children. However, there are certain groups that are at risk for severe disease and complications, such as children younger than 2 years old, adults aged 65 or older, pregnant women, patients with comorbidities, asthmatic patients, and patients with a weakened immune system.

Natural History, Complications and Prognosis

Influenza is a viral respiratory infection spread from person to person chiefly through droplet transmission. The incubation period period is 1 to 4 days. The uncomplicated influenza can present with constitutional symptoms and can resolve in 3-7 days; while others can develop into pneumonia, ear infection, encephalitis and sepsis.

Diagnosis

History and Symptoms

Influenza illness can include several non-specific symptoms, such as fever, muscle aches, headache, lack of energy, dry cough, sore throat, and runny nose. The fever and body aches can last 3-5 days and the cough and lack of energy may last for 2 or more weeks. The symptoms of the flu are more severe than their common-cold equivalents.

Physical Examination

During the physical examination in a patient with influenza, findings can include fever, tachycardia, tachypnea, sore throat, and fatigue. Complications can worsen the patient's condition and findings in the lung examination may include dry cough, rales and focal wheezing.

Laboratory Findings

Diagnostic tests available for influenza include viral culture, serology, rapid antigen testing, polymerase chain reaction (PCR), immunofluorescence assays, and rapid molecular assays. Sensitivity and specificity of any test for influenza might vary by the laboratory that performs the test, the type of test used, and the type of specimen tested. Among respiratory specimens for viral isolation or rapid detection, nasopharyngeal specimens are typically more effective than throat swab specimens. As with any diagnostic test, results should be evaluated in the context of other clinical and epidemiologic information available to health-care providers.

Chest X Ray

Chest X-ray is not routinely done in patients with influenza. A chest X-ray is useful to assess complications of influenza infection, such as a superimposed bacterial pneumonia.

Other Diagnostic Studies

Other diagnostic test for influenza include molecular assays, such as RT-PCR. New technologies being pursued include those that examine influenza viruses at the molecular level. By examining the genetic makeup of influenza viruses, such tests could identify both the virus type and subtype simultaneously.

Treatment

Medical Therapy

Antiviral drugs can diminish symptoms and shorten the time of the disease by 1 or 2 days. They also can prevent serious flu complications, such as pneumonia. For people with a high risk medical condition, treatment with an antiviral drug can mean the difference between having milder illness instead of very serious illness that could result in a hospital stay. The two main antivirals used in the treatment and prevention of influenza are oseltamivir and zanamivir. Symptomatic therapy is also important to overcome the symptoms of influenza, this include analgesics, antihistamines, decongestants and cough suppressants.

Primary Prevention

Vaccination and chemoprophylaxis are the two most important methods for preventing influenza among patients. Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. Annual influenza vaccination is the best way to prevent influenza because vaccination can be given well before influenza virus exposures occur, and can provide safe and effective immunity throughout the influenza season. Chemoprophylaxis is not recommended in all patients and should only be administered for certain populations who are at risk of complications.

Cost-Effectiveness of Therapy

Influenza produces direct costs due to lost productivity and associated medical treatment, as well as indirect costs of preventative measures. In the United States, influenza is responsible for a total cost of over $10 billion per year, while it has been estimated that a future pandemic could cause hundreds of billions of dollars in direct and indirect costs. However, the economic impact of past pandemics have not been intensively studied, and some authors have suggested that the Spanish influenza actually had a positive long-term effect on per-capita income growth, despite a large reduction in the working population and severe short-term depressive effects.[5] Other studies have attempted to predict the costs of a pandemic as serious as the 1918 Spanish flu on the U.S. economy, where 30% of all workers became ill, and 2.5% were killed. A 30% sickness rate and a three-week length of illness would decrease gross domestic product by 5%. Additional costs would come from medical treatment of 18 million to 45 million people, and total economic costs would be approximately $700 billion.[6]

Future or Investigational Therapies

Other antiviral drugs are being developed to treat influenza infection, such as peramivir. Vaccines are manufactured every year according to the subtype of influenza virus that causes the outbreak in that specific year.

References

  1. 1.0 1.1 Merck Manual Home Edition. "Influenza: Viral Infections".
  2. Eccles, R (2005). "Understanding the symptoms of the common cold and influenza". Lancet Infect Dis. 5 (11): 718–25. PMID 16253889.
  3. Seasonal Flu vs. Stomach Flu by Kristina Duda, R.N.; accessed March 12, 2007 (Website: "About, Inc., A part of The New York Times Company")
  4. "National Institute of Allergy and Infectious Diseases - Flu Overview".
  5. Brainerd, E. and M. Siegler (2003), “The Economic Effects of the 1918 Influenza Epidemic”, CEPR Discussion Paper, no. 3791.
  6. Poland G (2006). "Vaccines against avian influenza—a race against time". N Engl J Med. 354 (13): 1411–3. PMID 16571885.

Template:WH Template:WS